Gene · 6080
Papers2,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas. | Viruses | 2023 | 36680258 | PubTator, text mining | PubMed |
| Human Adenovirus Gene Expression and Replication Is Regulated through Dynamic Changes in Nucleoprotein Structure throughout Infection. | Viruses | 2023 | 36680201 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches Targeting Post-Translational Modifications in Lung Cancer. | Pharmaceutics | 2023 | 36678835 | PubTator, text mining | PubMed |
| Improving the Transduction Efficiency and Antitumor Effect of Conditionally Replicative Adenovirus by Application of 6-cyclohexyl Methyl-β-D-maltoside. | Molecules | 2023 | 36677587 | PubTator, text mining | PubMed |
| The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. | Biomolecules | 2023 | 36671544 | PubTator, text mining | PubMed |
| Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing. | Mol Ther Methods Clin Dev | 2023 | 36620071 | PubTator, text mining | PubMed |
| Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic. | Glob Chall | 2023 | 36618103 | PubTator, text mining | PubMed |
| Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages. | Cancer Cell Int | 2023 | 36604694 | PubTator, text mining | PubMed |
| The emerging field of oncolytic virus-based cancer immunotherapy. | Trends Cancer | 2023 | 36402738 | PubTator, text mining | PubMed |
| DNA methylation profile of lip tissue from congenital nonsyndromic cleft lip and palate patients by whole-genome bisulfite sequencing. | Birth Defects Res | 2023 | 36210532 | PubTator, text mining | PubMed |
| CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma. | Mol Ther | 2023 | 36056553 | PubTator, text mining | PubMed |
| Human papillomavirus infection, cervical cancer and the less explored role of trace elements. | Biol Trace Elem Res | 2023 | 35467267 | PubTator, text mining | PubMed |
| Human adenoviruses: A suspect behind the outbreak of acute hepatitis in children amid the COVID-19 pandemic. | Cell Insight | 2022 | 37192861 | PubTator, text mining | PubMed |
| The potential of cold-shock promoters for the expression of recombinant proteins in microbes and mammalian cells. | J Genet Eng Biotechnol | 2022 | 36580173 | PubTator, text mining | PubMed |
| Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy. | Front Pharmacol | 2022 | 36569326 | PubTator, text mining | PubMed |
| Strategies of Influenza A Virus to Ensure the Translation of Viral mRNAs. | Pathogens | 2022 | 36558855 | PubTator, text mining | PubMed |
| Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines: A Prospective Cohort Study. | Life (Basel) | 2022 | 36556411 | PubTator, text mining | PubMed |
| Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods. | Sci Rep | 2022 | 36543921 | PubTator, text mining | PubMed |
Characterization of the conserved regions of E1A protein from human adenovirus for reinforcement of cytotoxic T lymphocytes responses to the all genogroups causes ocular manifestation through an in silico approach. | Iran J Microbiol | 2022 | 36531810 | PubTator, text mining | PubMed |
| Machine Learning Prediction of Adenovirus D8 Conjunctivitis Complications from Viral Whole-Genome Sequence. | Ophthalmol Sci | 2022 | 36531578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6080/papers?page=7